CooperCompanies Announces Release Date for Third Quarter 2021
CooperCompanies (NYSE: COO) will release its third quarter 2021 financial results on September 2, 2021, at 4:15 PM ET. A conference call to discuss the results will follow at 5:00 PM ET, with the live dial-in available for U.S. listeners at 855-643-4430 and international listeners at 707-294-1332. The call will also be accessible via a webcast on the company's website. A recording of the call will be available from 8:00 PM ET on September 2 to September 9, 2021.
- Planned release of third quarter 2021 financial results may indicate ongoing business activities.
- Conference call scheduled for September 2 provides an opportunity for investor engagement.
- None.
SAN RAMON, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), today announced it will release third quarter 2021 financial results on Thursday, September 2, 2021, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.
The live dial-in number for the call is 855-643-4430 (U.S.) / 707-294-1332 (International). The participant passcode for the call is “Cooper”. A simultaneous webcast of the call will be available through the “Investor Relations” section of the CooperCompanies website at http://investor.coopercos.com and a transcript of the call will be archived on this site for a minimum of 12 months.
A recording of the call will be available beginning at 8:00 PM ET on September 2, 2021 through September 9, 2021. To hear this recording, dial 855-859-2056 (U.S.) / 404-537-3406 (International) and enter code 266737.
About CooperCompanies
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE: COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, CA, Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.
Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com
FAQ
When will CooperCompanies release its third quarter 2021 financial results?
What time is the conference call for CooperCompanies' financial results?
How can I access the webcast for CooperCompanies' financial results?